As we have previously noted, private equity (PE) firms have been increasingly drawn to the health care sector as a profitable investment opportunity. PE is a type of investment that involves pooling funds from investors in order to acquire companies with a goal of improving their financial performance to then sell them for a profit. One recent area of interest for PE firms has been gastroenterology, the branch of medicine that focuses on the digestive system and its disorders. Private equity firms are attracted to this field due to the steady demand for gastrointestinal (GI) services, which are required by patients of all ages and demographics. Additionally, the complexity of GI treatments and procedures creates a high barrier to entry for competitors, making it an attractive area for investors seeking long-term growth potential.